Keyphrases
New York City
100%
People Who Inject Drugs
59%
Syringe Services Programs
38%
HIV Infection
27%
Hepatitis C Virus
25%
Non-medical Use
25%
Herpes Simplex Virus 2 (HSV-2)
22%
Drug Users
20%
HIV Epidemic
19%
HIV Incidence
18%
Syringe Exchange
17%
Disparities in HIV
16%
AIDS/HIV
16%
HIV Transmission
15%
Confidence Interval
14%
Heroin
13%
Injection Drug Users
13%
Injection Drug Use
13%
Hepatitis C Treatment
13%
Israel
11%
People Who Use Drugs
11%
Adjusted Odds Ratio
11%
Drug Use
11%
Opioid Epidemic
10%
Fentanyl
10%
HIV Prevalence
10%
Syrinx
10%
Cocaine
9%
Risk Behavior
9%
Hepatitis C Virus Infection
9%
Injectable Drugs
9%
Integrated Prevention
9%
New Injectors
8%
High Prevalence
8%
Racial Disparities
8%
Crack Cocaine
8%
Viral Outbreaks
8%
Hispanic
8%
Heroin Users
7%
Cocaine Users
7%
Hepatitis C Virus Prevalence
7%
Heterosexual
7%
African American
7%
Non-fatal Overdose
7%
HIV Risk
7%
HIV Prevention
7%
Hepatitis C
6%
White People
6%
Respondent-driven Sampling
6%
Drug Overdose
6%
Medicine and Dentistry
Human Immunodeficiency Virus
94%
Drug Use
49%
Prevalence
33%
Hepatitis C Virus
27%
Human Immunodeficiency Virus Infection
27%
Diamorphine
25%
Hepatitis C
24%
COVID-19
23%
Odds Ratio
20%
Harm Reduction
19%
Methadone Treatment
19%
Non-Injecting Drug User
15%
Drug Administration
13%
Ethnic Disparity
13%
Human Immunodeficiency Virus Prevalence
13%
COVID-19 Vaccination
12%
Maintenance Therapy
12%
Gene Linkage
12%
Infection
11%
Opiate
10%
Immigrant
10%
Client
10%
Systematic Review
10%
Meta-Analysis
10%
Drug Therapy
10%
Substance Use
10%
COVID-19 Vaccine
9%
Care Coordination
9%
Hepatitis Virus
9%
Human Immunodeficiency Virus Risk Behavior
8%
Transgender
8%
Odds Ratio
7%
Health Care Cost
7%
Public Health
7%
Health Outcomes
7%
Clinical Trial
7%
Narcotic Analgesic Agent
7%
Fentanyl
6%
Hepatitis A
6%
Cost-Effectiveness Analysis
5%
Herpes Simplex Virus 2
5%
Mental Health
5%
Hepatitis B Virus
5%
Base
5%
Geographic Distribution
5%
Quality Adjusted Life Year
5%
Men Who Have Sex with Men
5%
Marginalised Population
5%
Anodyne
5%
Hepatitis A Virus
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
81%
Prevalence
49%
Diamorphine
41%
Hepatitis C
39%
Hepatitis C Virus
31%
Human Immunodeficiency Virus Infection
29%
Methadone
28%
Herpes Simplex Virus 2
23%
Duragesic
21%
Infection
19%
Illicit Drug
17%
Vaccination Policy
16%
Toxic Injury
15%
Virus Hepatitis
14%
Opiate
13%
Drug Overdose
12%
Pharmacotherapy
9%
Human Immunodeficiency Virus Prevalence
9%
Disease
7%
Cocaine
7%
Narcotic Analgesic Agent
7%
Hepatitis A
6%
Clinical Trial
6%
Hepatitis B Virus
6%
Pandemic
6%
Hepatitis A Virus
5%
Cannabis
5%
Virus Infection
5%
Methadone Treatment
5%
Geographic Distribution
5%
Analgesic Agent
5%
Hepacivirus
5%
Hepatitis B
5%